4th Dec 2018 11:21
LONDON (Alliance News) - OptiBiotix Health PLC said Tuesday it entered into a three-year agreement with an unnamed company to distribute SlimBiome Medical in Greece and Cyprus.
SlimBiome is the company's product to promote weight loss, fight food cravings and help dieting. At the end of November, SlimBiome had been granted medical device status and a CE mark.
The agreement grants the distributor exclusive rights in Greece and Cyprus and first right of refusal for the Gulf States, in return for meeting annual sales targets in order to retain exclusivity.
No further commercial details regarding the deal were disclosed.
OptiBiotix shares were trading down 1.5% at 97.55 pence each.
Related Shares:
OptiBiotix Health